Vivos (RDGL) Interest Coverage Ratio Growth (1y) (2011 - 2025)
Vivos (RDGL) Interest Coverage Ratio Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.08 Bn | 175.79 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 128.71 Bn | 125.83 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 108.79 Bn | 99.57 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 68.41 Bn | 66.96 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | 11.06% |
| 6 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | -6.18% |
| 7 | Dexcom | 28.34 Bn | 27.22 Bn | 750.30 Mn | 189.50% |
| 8 | Smith & Nephew | 26.87 Bn | 26.29 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | -54.61% |
| 10 | Vivos | 26.71 Mn | 25.15 Mn | -3,105.00 | 96.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 96.24% |
| Sep 30, 2025 | -49.49% |
| Jun 30, 2025 | -186.63% |
| Mar 31, 2025 | 38.33% |
| Dec 31, 2024 | 68.33% |
| Sep 30, 2024 | 71.64% |
| Jun 30, 2024 | 93.98% |
| Mar 31, 2024 | -117.77% |
| Dec 31, 2023 | 72.85% |
| Sep 30, 2023 | -16.52% |
| Jun 30, 2023 | -134.10% |
| Mar 31, 2023 | 70.64% |
| Dec 31, 2022 | -527.57% |
| Sep 30, 2022 | -781.50% |
| Jun 30, 2022 | 5.31% |
| Mar 31, 2022 | 68.04% |
| Dec 31, 2021 | 81.11% |
| Sep 30, 2021 | 49.20% |
| Jun 30, 2021 | -2,457.87% |
| Mar 31, 2021 | -7,052.94% |